Clinical Trials Browser

Colonic Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT03035357 2024-05-03

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT06301308 2024-04-24

A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial

Phase 3 Withdrawn

Genitourinary

Urinary Bladder Neoplasms

NCT05894447 2024-04-12

Naptumomab Estafenatox in Combination With Pembrolizumab Preceded by Obinutuzumab in Patients With Urothelial Cancers

Phase 1 Withdrawn

Genitourinary

Carcinoma, Transitional Cell

NCT04243941 2024-03-21

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms

Clinical Trials

N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer

Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer

Patient Recall of Cancer Screening and Diagnosis

PROTOMEN

Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC)

Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells

Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

HARMONY

A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology

REPRESENTATION

Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer

CHEMOPROST

PSMA Therapy and Immunotherapy in Kidney Cancer

TALON

iConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma

Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery

Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer

18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer

Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer

Dynamic Whole Body PET/ MRI

Prostate MRI and Pylarify PSMA PET/CT

Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis

The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient

A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in Arizona

KOALA

A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer

MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial

Laser Treatment of Genito-urinary Syndrome in Women

VS-UrineID

Using Meditation for Oncology Anxiety

ISABELLA

18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study

Clinical Performance Evaluation of the C2i Test

Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer

LUNAAR

Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Impact of Perioperative Anesthetic Management on Renal Cancer Progression.

Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy

TRACK

GI Organ Tracking Via Balloon Applicators

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial

Naptumomab Estafenatox in Combination With Pembrolizumab Preceded by Obinutuzumab in Patients With Urothelial Cancers

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer